Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
22 Results Found
Regulatory Relief to Promote Domestic Production of Critical Medicines
Directs the Commissioner of the Food and Drug Administration to review and eliminate any duplicative or unnecessary requirements in regulations and guidance pertaining to the development of domestic pharmaceutical manufacturing within 180 days.
Unleashing Prosperity Through Deregulation (10-1 order, caps on agency costs)
Requires agencies to identify at least 10 regulations to be repealed for each new regulation proposed or promulgated. Directs agencies to ensure total incremental cost of all new regulations for FY 2025, including repealed regulations, is less than $0.
AHA Provides Input to Administration on Efforts to Provide Regulatory Relief for Hospitals and Health Systems
The Department of Health and Human Services (HHS) May 13 announced a 60-day public comment period for stakeholders regarding its RFI to remove outdated or unnecessary regulations.
AHA Response to OMB Deregulation RFI
AHA responds to the Office of Management and Budget Deregulation Request for Information.
AHA Comments on FTC Anticompetitive Deregulations RFI
The AHA provides an overview of the key statutes and regulations that have impeded competition in the health care market and offer a series of recommendations to remedy these obstacles.
AHA Comments on DOJ Anticompetitive Deregulations RFI
The AHA provides an overview of the key statutes and regulations that have impeded competition in the health care market and offer a series of recommendations to remedy these obstacles.
AHA responds to DOJ, FTC anticompetitive regulation RFIs
AHA May 23 submitted recommendations to the Department of Justice and Federal Trade Commission in response to the agencies’ requests for information on unnecessary or burdensome anticompetitive regulations.
AHA makes 100 suggestions to Trump administration on providing regulatory relief
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump administration to help reduce burden on hospitals and health systems.
Litigation: AHA, Hospitals Sue to Require HHS to Meet Deadlines for Deciding Appeals
Appeals court sends order to eliminate backlog of Medicare appeals back to trial court (August 11, 2017)
Executive order promotes domestic production of medicines, other executive actions
The Trump administration May 5 issued two executive orders on pharmaceutical manufacturing and life-sciences research.